脑氧饱和度与体外膜氧合后结局的相关性
该单中心回顾性观察研究纳入2008年2月至2014年9月在儿科ICU接受ECMO并常规行脑rSO2监测的1天至20岁儿童,共153例患者156次ECMO运行。主要发现:92例(59%)出现rSO2≤50%,60例(38%)出现较基线下降>20%,26例(17%)出现较1小时前读数下降>20%。多变量校正后,rSO2≤50%和较基线下降>20%均与出院时不良结局相关(OR分别为2.82和4.52),而较1小时前下降>20%与结局无显著相关。作者认为rSO2下降与ECMO后短期不良神经结局和死亡相关,早期预防措施的效果需进一步研究。
要点
- 儿童ECMO期间rSO2≤50%与出院时不良神经结局或死亡相关(多变量校正OR 2.82,95%CI 1.10-7.25)。
- rSO2较基线下降>20%与出院时不良神经结局或死亡相关(多变量校正OR 4.52,95%CI 1.76-11.58)。
- rSO2较1小时前读数下降>20%与结局无显著关联。
- 153例患儿中99例(64%)存活出院,82/99(83%)存活者出院时PCPC≤2或较基线无下降。
- 135例(87%)行神经影像学检查,其中59例(44%)异常。
适用人群与场景
- 1天至20岁儿童,在儿科ICU接受ECMO并常规行脑rSO2监测(单中心,2008年2月至2014年9月)。
诊断标准与关键阈值
- 良好结局定义为出院时存活且儿科脑功能类别(PCPC)≤2或PCPC较基线无下降。
- 不良结局相关阈值:rSO2≤50%;rSO2较基线下降>20%。
红旗征与不能漏的情况
- ECMO期间rSO2≤50%或较基线下降>20%与出院时不良神经结局或死亡相关(多变量校正OR分别为2.82和4.52)。
研究设计与关键结果
- 回顾性观察研究,单中心,153例患者共156次ECMO运行,中位年龄12.5天(IQR 2天-15个月)。
- 99例(64%)存活出院,82/99(83%)存活者出院时PCPC≤2或较基线无下降。
- 135例(87%)行神经影像学检查,59例(44%)异常。
- 92例(59%)出现rSO2≤50%,60例(38%)出现较基线下降>20%,26例(17%)出现较1小时前读数下降>20%。
- 多变量校正后,rSO2≤50%与不良结局相关(OR 2.82,95%CI 1.10-7.25);较基线下降>20%与不良结局相关(OR 4.52,95%CI 1.76-11.58);较1小时前下降>20%与结局无显著关联。
证据类型、等级与局限
- 证据类型:单中心回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在ECMO期间常规临床rSO2监测的儿童中,rSO2下降与校正潜在混杂因素后的短期不良神经结局和死亡相关;对这些高危患者启动早期预防措施的有效性需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is associated with neurologic morbidity and mortality. We investigated whether cerebral regional oxygen saturation (rSO2) is associated with neurologic outcomes and survival in children on ECMO.
METHODS: This was a retrospective observational study of children aged 1 day to 20 years who underwent ECMO with routine cerebral rSO2 monitoring in the pediatric intensive care unit at a single academic center between February 2008 and September 2014. We collected all serial rSO2 values recorded in the electronic medical record during the ECMO course. Favorable outcome was defined as survival with Pediatric Cerebral Performance Category (PCPC) ≤ 2 at hospital discharge or no decline from baseline PCPC.
RESULTS: We reviewed data from 153 patients who underwent 156 ECMO runs. The median age was 12.5 days (interquartile range [IQR], 2 days-15 months). Ninety-nine (64%) patients survived to hospital discharge, and 82/99 (83%) survivors had favorable neurologic outcome by discharge PCPC. Neuroimaging studies were obtained in 135 (87%) patients, 59 (44%) of which showed abnormal findings. Ninety-two (59%) patients had any rSO2 ≤ 50%, 60 (38%) had any rSO2 decline > 20% from baseline, and 26 (17%) had any rSO2 decline > 20% from the reading 1 h prior. Any rSO2 ≤ 50% and any rSO2 decline > 20% from baseline were each associated with unfavorable outcome at hospital discharge (multivariable-adjusted odds ratio [OR], 2.82 [95% CI 1.10-7.25] and 4.52 [95% CI 1.76-11.58], respectively). rSO2 decline > 20% from the reading 1 h prior was not significantly associated with the outcomes.
CONCLUSION: Among children in one institution who underwent routine clinical rSO2 monitoring during ECMO, rSO2 decline was associated with unfavorable short-term neurologic outcome and death after adjusting for potential confounders. The effectiveness of initiating early preventative measures in these high-risk patients needs further study.
参考来源
- Tsou PY, Garcia AV, Yiu A, et al. Association of Cerebral Oximetry with Outcomes after Extracorporeal Membrane Oxygenation. Neurocrit Care. 2020. PMID: 31925732. doi:10.1007/s12028-019-00892-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。